Adamax
guinea pig
The Dose Guy’s verdictSep 1, 20260 sources
Skip it. Adamax has no published pharmacology, no animal data, no human data, and no described mechanism. It appears in vendor catalogs as an adamantane-family nootropic, riding on bromantane’s reputation, but nobody has published a single study on what it does or what it does to you. This is not thin evidence. This is no evidence.
What it is
An adamantane-based compound sold as a nootropic, sharing the cage-like chemical scaffold with amantadine, memantine, and bromantane. That family does real things: amantadine is an approved drug and bromantane has Russian clinical data. But sharing a scaffold is not sharing a mechanism. Adamax has no published target, no described receptor binding, no cell or animal study in the literature. The name appears in vendor listings alongside bromantane, but the resemblance ends at the chemistry. If the adamantane dopaminergic story is what you want, run bromantane. It earned its reputation with pharmacology. Adamax has a catalog listing.
What the research shows
There is no research to review:
Realistic protocols
I’m not building a protocol for a compound with zero published pharmacology. No mechanism, no dose-finding, no safety signal, nothing. The vendor-suggested doses floating around online are invented from whole cloth. If you run it, you are not even self-experimenting in a meaningful sense, because an experiment requires a hypothesis grounded in something.
Side effects
Nobody has studied a single effect or side effect of Adamax in any system:
